Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Chodankar

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Baseline characteristics of participants in the LANDMARC trial: A 3-year, <i>pan</i>-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusAshok K Das, Ambrish Mithal, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|December 2, 2021
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 11, 2020
Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS)Ambady Ramachandran, Sunil M Jain, Sagarika Mukherjee, et al.
Epilepsy & Behavior : E&B|April 5, 2022
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experienceParthasarathy Satishchandra, Chaturbhuj Rathore, Anirudha Apte, et al.
Epilepsy & Behavior : E&B|October 17, 2025
Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON studyParthasarathy Satishchandra, Chaturbhuj Rathore, Abhishek Kumar, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Baseline characteristics of participants in the LANDMARC trial: A 3-year, <i>pan</i>-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusAshok K Das, Ambrish Mithal, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|December 2, 2021
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 11, 2020
Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS)Ambady Ramachandran, Sunil M Jain, Sagarika Mukherjee, et al.
Epilepsy & Behavior : E&B|April 5, 2022
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experienceParthasarathy Satishchandra, Chaturbhuj Rathore, Anirudha Apte, et al.
Epilepsy & Behavior : E&B|October 17, 2025
Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON studyParthasarathy Satishchandra, Chaturbhuj Rathore, Abhishek Kumar, et al.
Pageof 2